COVID-19 response in low- and middle-income countries: Don’t overlook the role of mobile phone communication

Verhagen, Lilly M.; Groot, Ronald de; Lawrence, Charlene Ann; Taljaard, Jantjie; Cotton, Mark F.; Rabie, Helena

doi:10.1016/j.ijid.2020.07.069

Cited by 36 publications

(33 citation statements)

References 24 publications

(32 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is supported by Meadows who outlines information flows and their structure as an effective leverage point, with missing feedback identified as one of the most common causes of system failure (Meadows, 2008; Stanton & Harvey, 2017). Indeed, clarity of reporting and communication have been identified as an issue limiting the effectiveness of the response to COVID‐19 (Verhagen et al, 2020). Further, risk awareness at the community level has been labeled as one of the most effective ways to slow or prevent transmission of COVID‐19 (Chatterjee et al, 2020).…”

Section: Discussionmentioning

confidence: 99%

Human Factors and Ergonomics and the management of existential threats: A work domain analysis of a COVID‐19 return from lockdown restrictions system

Salmon

Stevens

McLean

et al. 2021

Hum Ftrs & Erg Mfg Svc

View full text Add to dashboard Cite

Following strict “lockdown” restrictions designed to control the spread of the COVID‐19 virus, many jurisdictions are now engaged in a process of easing restrictions in an attempt to stimulate economic and social activity while continuing to suppress virus transmission. This is challenging and complex, and in several regions, new outbreaks have emerged. We argue that systems Human Factors and Ergonomics methods can assist in understanding and optimizing the return from lockdown. To demonstrate, we used work domain analysis to develop an abstraction hierarchy model of a generic “return from lockdown restrictions” system. The model was assessed to identify (a) issues preventing a successful return from lockdown; and (b) leverage points that could be exploited to optimize future processes. The findings show that the aim of continuing to suppress virus transmission conflicts with the aims of returning to pre‐virus economic and social activity levels. As a result, many functions act against each other, ensuring that the system cannot optimally achieve all three of its primary aims. Potential leverage points include modifying the goals and rules of the system and enhancing communications and feedback. Specifically, it is argued that moderating economic aims and modifying how social and community activities are undertaken will result in longer term suppression of the virus.

show abstract

Section: Discussionmentioning

confidence: 99%

Human Factors and Ergonomics and the management of existential threats: A work domain analysis of a COVID‐19 return from lockdown restrictions system

Salmon

Stevens

McLean

et al. 2021

Hum Ftrs & Erg Mfg Svc

View full text Add to dashboard Cite

show abstract

“…104,[206][207][208][209][210][211] It has been reported that COVID-19 has been a neglected issue in LMICs. 212,213 Internationally, eight of the ten nations with the highest numbers of new cases of COVID-19 are upper middle income (Peru, Russia, South Africa, Argentina, Colombia, Mexico, Brazil) or lowermiddle-income states (India). 212 It has been reported that in compassion to high-income countries (HICs), CCP transfusions have received scant attention in LMICs.…”

Section: Discussionmentioning

confidence: 99%

“… 212 It has been reported that in compassion to high-income countries (HICs), CCP transfusions have received scant attention in LMICs. 213 Multiple reasons have been identified as the systemic challenges of resource-poor settings. Several LMICs do not possess a safe and reliable blood transfusion facility; this situation existed before COVID-19 due to poor donor enlistment and deployment, collections process, distribution, lack of infectious testing capability, and transfusion itself.…”

Section: Discussionmentioning

confidence: 99%

<p>Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic</p>

Samad¹,

Sodunke²,

Banna³

et al. 2020

RMHP

View full text Add to dashboard Cite

The world is striving against the severe crisis of the COVID-19 pandemic. Healthcare professionals are struggling to treat their patients based on nonspecific therapies. Amidst this uncertainty, convalescent plasma therapy (CPT) has appeared to be an interim adjuvant therapy for severely ill patients of COVID-19 until long-term clinical trial treatment options are available. Considering the transfusion-related hazards, especially lung injuries and microbial transmission, where sensitivity is not ensured, rigorous trials should be conducted to determine this therapy's efficacy. Moreover, the ratio of recovered cases to plasma donors is not satisfying, which questioning this therapy's availability and accessibility. Although some countries are making the treatment free, the attributable cost mandates a justification for its suitability and sustainability. Our article aimed to review the published facts and findings of CPT's effectiveness in lowering the mortality rate of COVID-19. This pandemic showed that healthcare systems worldwide need core reform. A unified global collaboration must align and coordinate to face the current pandemic and enhance world readiness for future outbreaks based on health equity and equality.

show abstract

“…LMICs, even on a good day, are resource deficient and certainly not prepared to deal with a healthcare crisis of this magnitude despite a lower disease burden of COVID-19 infections [ 5 ]. Though the healthcare community, and specifically leading oncologic societies such as the American Society of Clinical Oncology (ASCO) and the European Society of Medical Oncology (ESMO), put together triaging recommendations to best utilize resources without compromising care, these guidelines are not applicable to all LMICs, as each country struggles with its unique challenges.…”

Section: Introductionmentioning

confidence: 99%

The Novel Coronavirus (COVID-19) Pandemic and the Response in Low-to-Middle Income Countries

Shahzad

Mubarik

Sattar

2021

Curr Breast Cancer Rep

View full text Add to dashboard Cite

Purpose of Review The COVID-19 pandemic has posed an unprecedented challenge to healthcare, particularly in resource-constrained low and middle-income countries (LMICs). We aim to summarize the challenges faced by LMICs in providing breast cancer care during the pandemic and their response during this crisis. Recent Findings Conversion of oncology centers into COVID-19 isolation centers and lack of LMIC applicable guidelines for breast cancer treatment worsened the challenge for providers. Few LMICs changed their management framework, taking steps like triaging patients, prioritizing care, therapeutic spacing, and a shift to telehealth. Summary Modified protocols where available have served LMICs well for resource allocation; however, effectiveness of these cannot be determined due to lack of outcomes reporting. This pandemic has underscored the importance of flexibility, prompt intervention, good communication, and reassessment to address unexpected healthcare challenges and has been a learning lesson to help tailor guidelines early in the future.

show abstract

COVID-19 response in low- and middle-income countries: Don’t overlook the role of mobile phone communication

Cited by 36 publications

References 24 publications

Human Factors and Ergonomics and the management of existential threats: A work domain analysis of a COVID‐19 return from lockdown restrictions system

Human Factors and Ergonomics and the management of existential threats: A work domain analysis of a COVID‐19 return from lockdown restrictions system

<p>Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic</p>

The Novel Coronavirus (COVID-19) Pandemic and the Response in Low-to-Middle Income Countries

Contact Info

Product

Resources

About